292 related articles for article (PubMed ID: 20097709)
1. Genotype and tissue-specific effects on alternative splicing of the transcription factor 7-like 2 gene in humans.
Mondal AK; Das SK; Baldini G; Chu WS; Sharma NK; Hackney OG; Zhao J; Grant SF; Elbein SC
J Clin Endocrinol Metab; 2010 Mar; 95(3):1450-7. PubMed ID: 20097709
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific alternative splicing of TCF7L2.
Prokunina-Olsson L; Welch C; Hansson O; Adhikari N; Scott LJ; Usher N; Tong M; Sprau A; Swift A; Bonnycastle LL; Erdos MR; He Z; Saxena R; Harmon B; Kotova O; Hoffman EP; Altshuler D; Groop L; Boehnke M; Collins FS; Hall JL
Hum Mol Genet; 2009 Oct; 18(20):3795-804. PubMed ID: 19602480
[TBL] [Abstract][Full Text] [Related]
3. Unique splicing pattern of the TCF7L2 gene in human pancreatic islets.
Osmark P; Hansson O; Jonsson A; Rönn T; Groop L; Renström E
Diabetologia; 2009 May; 52(5):850-4. PubMed ID: 19247628
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes.
Prokunina-Olsson L; Kaplan LM; Schadt EE; Collins FS
PLoS One; 2009 Sep; 4(9):e7231. PubMed ID: 19789636
[TBL] [Abstract][Full Text] [Related]
5. An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes.
Locke JM; Da Silva Xavier G; Rutter GA; Harries LW
Diabetologia; 2011 Dec; 54(12):3078-82. PubMed ID: 21913056
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets.
Weise A; Bruser K; Elfert S; Wallmen B; Wittel Y; Wöhrle S; Hecht A
Nucleic Acids Res; 2010 Apr; 38(6):1964-81. PubMed ID: 20044351
[TBL] [Abstract][Full Text] [Related]
7. Impact of TCF7L2 rs7903146 on insulin secretion and action in young and elderly Danish twins.
Wegner L; Hussain MS; Pilgaard K; Hansen T; Pedersen O; Vaag A; Poulsen P
J Clin Endocrinol Metab; 2008 Oct; 93(10):4013-9. PubMed ID: 18611970
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
Lyssenko V; Lupi R; Marchetti P; Del Guerra S; Orho-Melander M; Almgren P; Sjögren M; Ling C; Eriksson KF; Lethagen AL; Mancarella R; Berglund G; Tuomi T; Nilsson P; Del Prato S; Groop L
J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651
[TBL] [Abstract][Full Text] [Related]
9. A partial cDNA sequence of the ovine insulin receptor gene: evidence for alternative splicing of an exon 11 region and for tissue-specific regulation of receptor isoform expression in sheep muscle, adipose tissue and liver.
McGrattan PD; Wylie AR; Bjourson AJ
J Endocrinol; 1998 Dec; 159(3):381-7. PubMed ID: 9834455
[TBL] [Abstract][Full Text] [Related]
10. Differential transcriptional and posttranslational transcription factor 7-like regulation among nondiabetic individuals and type 2 diabetic patients.
Pradas-Juni M; Nicod N; Fernández-Rebollo E; Gomis R
Mol Endocrinol; 2014 Sep; 28(9):1558-70. PubMed ID: 25058603
[TBL] [Abstract][Full Text] [Related]
11. Alternative human liver transcripts of TCF7L2 bind to the gluconeogenesis regulator HNF4α at the protein level.
Neve B; Le Bacquer O; Caron S; Huyvaert M; Leloire A; Poulain-Godefroy O; Lecoeur C; Pattou F; Staels B; Froguel P
Diabetologia; 2014 Apr; 57(4):785-96. PubMed ID: 24463962
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of TCF7L2 genetic variants associated with type 2 diabetes.
Pang DX; Smith AJ; Humphries SE
Nutr Metab Cardiovasc Dis; 2013 Jun; 23(6):550-6. PubMed ID: 22402060
[TBL] [Abstract][Full Text] [Related]
13. Evidence for neuroendocrine function of a unique splicing form of TCF7L2 in human brain, islets and gut.
Prokunina-Olsson L; Hall JL
Diabetologia; 2010 Apr; 53(4):712-6. PubMed ID: 20033802
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes.
Yu J; Steck AK; Babu S; Yu L; Miao D; McFann K; Hutton J; Eisenbarth GS; Klingensmith G
J Clin Endocrinol Metab; 2009 Feb; 94(2):504-10. PubMed ID: 19050058
[TBL] [Abstract][Full Text] [Related]
15. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes.
Haupt A; Thamer C; Heni M; Ketterer C; Machann J; Schick F; Machicao F; Stefan N; Claussen CD; Häring HU; Fritsche A; Staiger H
Diabetes; 2010 Mar; 59(3):747-50. PubMed ID: 20028944
[TBL] [Abstract][Full Text] [Related]
16. TCF7L2 polymorphisms are associated with type 2 diabetes in Khatri Sikhs from North India: genetic variation affects lipid levels.
Sanghera DK; Nath SK; Ortega L; Gambarelli M; Kim-Howard X; Singh JR; Ralhan SK; Wander GS; Mehra NK; Mulvihill JJ; Kamboh MI
Ann Hum Genet; 2008 Jul; 72(Pt 4):499-509. PubMed ID: 18397358
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance.
Damcott CM; Pollin TI; Reinhart LJ; Ott SH; Shen H; Silver KD; Mitchell BD; Shuldiner AR
Diabetes; 2006 Sep; 55(9):2654-9. PubMed ID: 16936218
[TBL] [Abstract][Full Text] [Related]
18. Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes.
Hansson O; Zhou Y; Renström E; Osmark P
Curr Diab Rep; 2010 Dec; 10(6):444-51. PubMed ID: 20878273
[TBL] [Abstract][Full Text] [Related]
19. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study.
Stolerman ES; Manning AK; McAteer JB; Fox CS; Dupuis J; Meigs JB; Florez JC
Diabetologia; 2009 Apr; 52(4):614-20. PubMed ID: 19183934
[TBL] [Abstract][Full Text] [Related]
20. Effects of TCF7L2 polymorphisms on obesity in European populations.
Cauchi S; Choquet H; Gutiérrez-Aguilar R; Capel F; Grau K; Proença C; Dina C; Duval A; Balkau B; Marre M; Potoczna N; Langin D; Horber F; Sørensen TI; Charpentier G; Meyre D; Froguel P
Obesity (Silver Spring); 2008 Feb; 16(2):476-82. PubMed ID: 18239663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
